HOMEOPATHY
The Most Sophisticated Commercial Placebo of the Modern Health Market
Neuromarketing, Therapeutic Perception, Placebo Neurobiology and Evidence-Based Medicine
Critical Scientific–Behavioural Audit Updated 2026
By DrRamonReyesMD ⚕️
Homeopathy can be defined, from a rigorous medical-scientific standpoint, as a therapeutic system historically structured around expectation, ritual, suggestion, perceived safety, symbolic authority, prolonged consultation and placebo response, but without robust, reproducible and clinically convincing evidence of specific efficacy beyond placebo for any concrete disease. In 2026, the Spanish Ministry of Health, through the Spanish Agency for Medicines and Medical Devices (AEMPS), concluded that there is no scientific evidence supporting the efficacy of homeopathy for any pathology.
This does not mean that every user is lying, nor that all perceived improvement is imaginary. The phenomenon is more complex: homeopathy exploits real mechanisms of perception, expectation, symptom modulation and therapeutic ritual, but it has not demonstrated a specific pharmacological mechanism compatible with modern pharmacology, biochemistry or evidence-based medicine.
1. Conceptual Audit
Homeopathy is based on two classical doctrines: “like cures like” and serial dilution with alleged “potentiation”. The fundamental scientific problem appears when many products are diluted beyond the Avogadro limit, making it statistically improbable that even one molecule of the original substance remains.
Modern pharmacology requires dose, concentration, receptor interaction, pharmacokinetics, pharmacodynamics, measurable biological effect, reproducibility and safety surveillance. Ultra-diluted homeopathy breaks this causal chain: no verifiable molecular dose, no conventional dose–response relationship, no reproducible receptor mechanism, no accepted pharmacological pathway and no consistent clinical efficacy in high-quality trials.
2. Placebo Is Real — Homeopathy Commercialises It Brilliantly
The placebo effect is not “fake”. It is a real neurobiological phenomenon involving expectation, conditioning, endogenous opioids, dopamine, reward circuits and descending pain modulation. Placebo responses may influence subjective symptoms such as pain, anxiety, nausea, perceived fatigue and emotional distress.
But placebo has biological limits. It does not sterilise bacteraemia, drain abscesses, reverse hypoxia, cure sepsis, reperfuse myocardial infarction, stop internal bleeding, eradicate cancer, replace insulin, replace antibiotics, or substitute adrenaline in anaphylaxis.
That is the critical distinction: placebo can modulate perception; it does not replace physiology-based treatment for objective disease.
3. Homeopathy as Therapeutic Neuromarketing
Homeopathy rarely sells only globules, drops or tablets. It sells a full therapeutic experience:
consultation time, listening, personalised language, “natural” identity, ritual, Latin names, small bottles, perceived gentleness, anti-industrial symbolism, distrust of “aggressive medicine” and emotional reassurance.
Its commercial strength depends on cognitive and behavioural mechanisms:
Naturalness bias: “natural” is perceived as safer, although many natural substances are toxic or lethal.
Confirmation bias: improvement is remembered; failure is forgotten.
Regression to the mean: many conditions fluctuate; patients seek help when symptoms peak, then improve naturally.
Illusion of causality: “I took it and improved” becomes “it worked”.
Authority effect: pharmacy shelves, white coats, technical language and tradition increase credibility.
Therapeutic ritual: repeated dosing instructions increase expectation and perceived control.
For that reason, homeopathy operates commercially as a high-adherence ritualised placebo.
4. Clinical Evidence: The Pattern Is Consistent
The scientific pattern is repetitive: small, heterogeneous, poorly registered or lower-quality trials are more likely to suggest benefit; better-designed, better-controlled and less biased studies tend to show effects compatible with placebo.
The influential Lancet comparative meta-analysis by Shang et al. concluded that the clinical effects of homeopathy were compatible with placebo effects when trial quality and bias were considered. DOI: 10.1016/S0140-6736(05)67177-2.
A systematic review of systematic reviews by Ernst concluded that available evidence did not support homeopathy as clinically effective beyond placebo. DOI: 10.1093/fampra/19.6.643.
A 2022 BMJ Evidence-Based Medicine analysis found major reporting-bias problems in homeopathy trials: a substantial proportion of registered trials remained unpublished, many published randomised trials were not registered, and primary outcomes were sometimes changed. DOI: 10.1136/bmjebm-2021-111846.
5. Strong Institutional Assessments
The Australian NHMRC concluded that there is no reliable evidence that homeopathy is effective for the health conditions evaluated. Spain’s AEMPS published a 2026 technical report concluding that there is no scientific evidence supporting homeopathy as a therapeutic instrument.
The European Academies’ Science Advisory Council has also recommended an evidence-based approach and warned against presenting homeopathic products as effective without robust scientific proof. Spain’s 2026 report aligns with this broader European movement against pseudotherapies and unsupported therapeutic claims.
The Spanish Ministry of Health also stated in April 2026 that no homeopathic product in Spain has an authorised therapeutic indication, while products allowed to remain registered cannot claim therapeutic indications.
6. Regulation, Advertising and Commercial Risk
Regulation does not equal proof of efficacy. A product may be legally sold while lacking authorised therapeutic indications.
In Spain, AEMPS reported that homeopathic products had historically remained on the market under transitional provisions, and the 2026 technical report forms part of a regulatory effort to clarify their efficacy and safety status.
In the United States, the Federal Trade Commission has required marketing claims for over-the-counter homeopathic drugs to be supported by competent and reliable scientific evidence. The FDA has also developed a risk-based enforcement approach for homeopathic drug products marketed without FDA approval.
7. The Real Clinical Risk: Delaying Effective Medicine
The main danger of homeopathy is usually not direct toxicity from an ultra-diluted globule. The central danger is clinical opportunity cost: delaying diagnosis or replacing effective therapy.
This is especially dangerous in:
sepsis, meningitis, pneumonia, tuberculosis, malaria, anaphylaxis, acute myocardial infarction, stroke, cancer, diabetic ketoacidosis, appendicitis, deep abscess, complicated pregnancy, serious paediatric disease, trauma, haemorrhage and shock.
Spain’s 2026 AEMPS report explicitly warned that the risk of homeopathy includes abandoning or delaying effective treatments.
8. Evidence-Based Medicine vs Homeopathic Belief
Evidence-based medicine is imperfect, but self-correcting. It uses clinical trials, pharmacovigilance, peer review, systematic reviews, meta-analyses, guideline updates and withdrawal of unsafe or ineffective treatments.
Homeopathy relies mainly on tradition, narrative, subjective perception, consultation time, cultural authority, the “natural” identity and cognitive bias. Its core problem is not only weak evidence; it is lack of biological plausibility when preparations are diluted beyond molecular presence.
9. Final DrRamonReyesMD Position
Homeopathy is probably the most sophisticated commercial placebo and therapeutic neuromarketing system in modern healthcare.
Not because it has demonstrated a specific, molecular, reproducible pharmacological action superior to placebo, but because it understands the psychology of illness: fear, uncertainty, need for listening, desire for control, rejection of toxicity, institutional distrust, meaning-seeking and hope.
The scientifically honest conclusion is:
Homeopathy may produce subjective relief through placebo, expectation, ritual and therapeutic interaction, but it has not demonstrated robust specific efficacy superior to placebo under modern evidence-based medical standards.
Scientific medicine must fight pseudoscience, but it must also learn an uncomfortable lesson: when healthcare becomes cold, rushed, bureaucratic and impersonal, the emotional placebo market occupies the space abandoned by the doctor–patient relationship.
By DrRamonReyesMD ⚕️ | Updated 2026
No hay comentarios:
Publicar un comentario